Analysis of HIV-1 CRF_01 a/E Protease Inhibitor Resistance: Structural Determinants for Maintaining Sensitivity and Developing Resistance to Atazanavir†

Biochemistry - United States
doi 10.1021/bi051886s
Full Text
Abstract

Available in full text

Categories
Biochemistry
Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Coevolutionary Analysis of Resistance-Evading Peptidomimetic Inhibitors of HIV-1 Protease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Design, Synthesis, and Biological and Structural Evaluations of Novel HIV-1 Protease Inhibitors to Combat Drug Resistance

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2012English

Targeting Structural Flexibility in HIV-1 Protease Inhibitor Binding

Drug Discovery Today
Drug DiscoveryPharmacology
2007English

HIV-1 Protease With 20 Mutations Exhibits Extreme Resistance to Clinical Inhibitors Through Coordinated Structural Rearrangements

Biochemistry
Biochemistry
2012English

Anti-Hiv Drugs and Resistance: Inhibitors of HIV-1 Reverse Transcriptase and Protease

2012English

Molecular Basis of HIV-1 Protease Drug Resistance: Structural Analysis of Mutant Proteases Complexed With Cyclic Urea Inhibitors

Biochemistry
Biochemistry
1997English

HIV Seems to Develop a Resistance to Experimental Protease Inhibitors

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Structure-Based Design of Novel HIV-1 Protease Inhibitors to Combat Drug Resistance

English

187 Drug Resistance: Crystallography of Drug-Resistant HIV-1 Protease Mutant

Journal of Biomolecular Structure and Dynamics
MedicineMolecular BiologyStructural Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy